X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-22 | ANAB | Faga Daniel | CEO | S - Sale | $22.76 | -148,940 | 401,646 | -27% | -$3,389,452 | |||||
| D | 2024-02-16 | ANAB | Loumeau Eric J | GC | S - Sale+OE | $25.00 | -5,000 | 3,240 | -61% | -$125,000 | |||||
2024-01-30 | ANAB | Mulroy Dennis | CFO | S - Sale | $23.63 | -3,065 | 964 | -76% | -$72,425 | ||||||
| D | 2024-01-08 | ANAB | Lizzul Paul F. | Chief Medical Officer | S - Sale+OE | $21.81 | -2,554 | 10,118 | -20% | -$55,703 | |||||
| D | 2024-01-08 | ANAB | Loumeau Eric J | GC | S - Sale+OE | $21.81 | -2,305 | 3,240 | -42% | -$50,272 | |||||
| D | 2024-01-08 | ANAB | Mulroy Dennis | CFO | S - Sale+OE | $21.81 | -2,180 | 4,029 | -35% | -$47,546 | |||||
| D | 2024-01-08 | ANAB | Faga Daniel | CEO | S - Sale+OE | $21.81 | -6,866 | 898,027 | -1% | -$149,747 | |||||
2023-11-22 | ANAB | Loumeau Eric J | GC | S - Sale | $14.19 | -882 | 0 | -100% | -$12,516 | ||||||
| D | 2023-09-14 | ANAB | Lizzul Paul F. | Chief Medical Officer | S - Sale+OE | $19.48 | -2,105 | 6,527 | -24% | -$41,005 | |||||
| DM | 2023-09-14 | ANAB | Loumeau Eric J | GC | S - Sale+OE | $19.37 | -6,000 | 882 | -87% | -$116,238 | |||||
| DM | 2023-09-14 | ANAB | Mulroy Dennis | CFO | S - Sale+OE | $19.37 | -6,000 | 964 | -86% | -$116,242 | |||||
| D | 2022-06-08 | ANAB | Loumeau Eric J | COO, GC | S - Sale+OE | $24.00 | -2,500 | 523 | -83% | -$60,000 | |||||
2022-05-18 | ANAB | Loumeau Eric J | COO, GC | S - Sale | $20.50 | -1,146 | 523 | -69% | -$23,493 | ||||||
2022-05-05 | ANAB | Ecor1 Capital, LLC | 10% | P - Purchase | $21.63 | +668,237 | 15,042,048 | +5% | +$14,453,966 | ||||||
2022-05-05 | ANAB | Ecor1 Capital, LLC | 10% | S - Sale | $21.63 | -668,237 | 15,042,048 | -4% | -$14,453,966 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |